wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37728232-A68BCB20-371F-41C1-8394-B8AF3B6BD6CC
Q37728232-A68BCB20-371F-41C1-8394-B8AF3B6BD6CC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37728232-A68BCB20-371F-41C1-8394-B8AF3B6BD6CC
Low dosages: new chemotherapeutic weapons on the battlefield of immune-related disease.
P2860
Q37728232-A68BCB20-371F-41C1-8394-B8AF3B6BD6CC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37728232-A68BCB20-371F-41C1-8394-B8AF3B6BD6CC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2cb9d2f17887d33d0d15d39f8c9c8619f77d008c
P2860
Ten-year follow-up of a phase 2 study of dose-intense paclitaxel with cisplatin and cyclophosphamide as initial therapy for poor-prognosis, advanced-stage epithelial ovarian cancer.